Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of $1.19 billion. The enterprise value is $1.48 billion.
Important Dates
The last earnings date was Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.67 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 177.67M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 38.16% |
| Float | 130.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.34 |
| Forward PS | n/a |
| PB Ratio | 1.27 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 720.56 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.66 |
| EV / EBITDA | 96,860.42 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.61.
| Current Ratio | 2.12 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 22.50 |
| Debt / FCF | n/a |
| Interest Coverage | -5.37 |
Financial Efficiency
Return on equity (ROE) is -17.98% and return on invested capital (ROIC) is -3.72%.
| Return on Equity (ROE) | -17.98% |
| Return on Assets (ROA) | -2.69% |
| Return on Invested Capital (ROIC) | -3.72% |
| Return on Capital Employed (ROCE) | -5.80% |
| Revenue Per Employee | $187,214 |
| Profits Per Employee | -$39,352 |
| Employee Count | 4,740 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 20.15 |
Taxes
In the past 12 months, Evotec SE has paid $31.54 million in taxes.
| Income Tax | 31.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.84% in the last 52 weeks. The beta is 1.08, so Evotec SE's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -27.84% |
| 50-Day Moving Average | 3.75 |
| 200-Day Moving Average | 3.91 |
| Relative Strength Index (RSI) | 27.76 |
| Average Volume (20 Days) | 55,222 |
Short Selling Information
| Short Interest | 542,955 |
| Short Previous Month | 644,040 |
| Short % of Shares Out | 0.15% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.04 |
Income Statement
In the last 12 months, Evotec SE had revenue of $887.40 million and -$186.53 million in losses. Loss per share was -$1.06.
| Revenue | 887.40M |
| Gross Profit | 96.04M |
| Operating Income | -95.16M |
| Pretax Income | -154.99M |
| Net Income | -186.53M |
| EBITDA | 15,253 |
| EBIT | -95.16M |
| Loss Per Share | -$1.06 |
Full Income StatementBalance Sheet
The company has $278.39 million in cash and $568.60 million in debt, giving a net cash position of -$290.21 million or -$1.63 per share.
| Cash & Cash Equivalents | 278.39M |
| Total Debt | 568.60M |
| Net Cash | -290.21M |
| Net Cash Per Share | -$1.63 |
| Equity (Book Value) | 938.80M |
| Book Value Per Share | 5.28 |
| Working Capital | 491.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.65 million and capital expenditures -$85.71 million, giving a free cash flow of -$82.67 million.
| Operating Cash Flow | 1.65M |
| Capital Expenditures | -85.71M |
| Free Cash Flow | -82.67M |
| FCF Per Share | -$0.47 |
Full Cash Flow StatementMargins
Gross margin is 10.82%, with operating and profit margins of -10.72% and -21.02%.
| Gross Margin | 10.82% |
| Operating Margin | -10.72% |
| Pretax Margin | -17.47% |
| Profit Margin | -21.02% |
| EBITDA Margin | 0.00% |
| EBIT Margin | -10.72% |
| FCF Margin | n/a |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | -0.19% |
| Earnings Yield | -15.65% |
| FCF Yield | -6.93% |
Dividend DetailsAnalyst Forecast
The average price target for Evotec SE is $7.00, which is 111.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 111.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 7.19% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 20, 2021. It was a forward split with a ratio of 4:1.
| Last Split Date | Oct 20, 2021 |
| Split Type | Forward |
| Split Ratio | 4:1 |
Scores
Evotec SE has an Altman Z-Score of 0.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.72 |
| Piotroski F-Score | 5 |
